ID   SGMR2_RAT               Reviewed;         176 AA.
AC   Q5U3Y7;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   24-JUL-2024, entry version 100.
DE   RecName: Full=Sigma intracellular receptor 2 {ECO:0000250|UniProtKB:Q5BJF2};
DE            Short=Sigma-2 receptor {ECO:0000250|UniProtKB:Q5BJF2};
DE            Short=Sigma2 receptor {ECO:0000250|UniProtKB:Q5BJF2};
DE   AltName: Full=Transmembrane protein 97 {ECO:0000250|UniProtKB:Q5BJF2};
GN   Name=Tmem97 {ECO:0000312|RGD:1307423};
GN   Synonyms=S2r {ECO:0000250|UniProtKB:Q5BJF2};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Sigma-2 receptor which contributes to ameliorate
CC       dysfunctional cellular processes and slow degenerative progression by
CC       regulating cell functions including cholesterol
CC       biosynthesis/trafficking, membrane trafficking, autophagy, lipid
CC       membrane-bound protein trafficking, and receptor stabilization at the
CC       cell surface. Forms a ternary complex with PGRMC1 receptor and low
CC       density lipoprotein receptor/LDLR at the plasma membrane, which
CC       increases LDLR-mediated LDL cholesterol internalization. Decreases
CC       lysosomal sterol transporter NPC1 availability to the cell, probably
CC       through NPC1-binding, hence controlling lipid transport, including
CC       cholesterol and LBPA, outside of late endosome/lysosome. Binds
CC       regio- and stereoselective ligand 20(S)-hydroxycholesterol (20(S)-OHC)
CC       which enhances TMEM97-NPC1 interaction and decreases TMEM97-PGRMC1 and
CC       TMEM97-TSPO interactions, thereby linking OHC binding to cholesterol
CC       homeostasis (By similarity). Also able to bind cholesterol (By
CC       similarity). Binds histatin 1 (Hst 1)/HN1 salivary peptide at the ER
CC       membrane, which is critical for increasing mitochondria-ER contacts and
CC       stimulating Hst1 wound healing properties. May alter the activity of
CC       some cytochrome P450 proteins. Although shows homologies with sterol
CC       isomerases (EXPERA domain), not able to catalyze sterol isomerization.
CC       However, may act as sensors of these molecules (By similarity). Acts as
CC       a quality control factor in the ER, promoting the proteolytic
CC       degradation of nonproductive and extramitochondrial precursor proteins
CC       in the ER membrane thus removing them from the ER surface (By
CC       similarity). {ECO:0000250|UniProtKB:Q12155,
CC       ECO:0000250|UniProtKB:Q3MHW7, ECO:0000250|UniProtKB:Q5BJF2}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with NPC1; the
CC       interaction impairs NPC1-mediated cholesterol transport. Interacts with
CC       PGRMC1 and LDLR; the interaction increases LDL internalization.
CC       Interacts with histatin 1/HTN1; the interaction induces HTN1-
CC       stimulating wound healing. Interacts with TSPO (By similarity).
CC       {ECO:0000250|UniProtKB:Q3MHW7, ECO:0000250|UniProtKB:Q5BJF2}.
CC   -!- SUBCELLULAR LOCATION: Rough endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q5BJF2}; Multi-pass membrane protein
CC       {ECO:0000255}. Nucleus membrane {ECO:0000250|UniProtKB:Q5BJF2}; Multi-
CC       pass membrane protein {ECO:0000255}.
CC   -!- DOMAIN: The EXPERA domain doesn't possess any sterol isomerase
CC       catalytic activity. {ECO:0000250|UniProtKB:Q5BJF2}.
CC   -!- DOMAIN: The four transmembrane helices are all kinked owing to the
CC       presence of proline residues in each, creating a ligand-binding cavity
CC       near the center of the protein. {ECO:0000250|UniProtKB:Q3MHW7}.
CC   -!- MISCELLANEOUS: Sigma receptors are classified into two subtypes (Sigma-
CC       1 and Sigma-2) based on their different pharmacological profile. Sigma-
CC       2 receptors are identified by radioligand-binding studies as a binding
CC       site with high affinity for di-o-tolylguanidine (DTG) and haloperidol.
CC       {ECO:0000250|UniProtKB:Q5BJF2}.
CC   -!- SIMILARITY: Belongs to the TMEM97/sigma-2 receptor family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC085344; AAH85344.1; -; mRNA.
DR   RefSeq; NP_001008335.1; NM_001008334.1.
DR   AlphaFoldDB; Q5U3Y7; -.
DR   SMR; Q5U3Y7; -.
DR   STRING; 10116.ENSRNOP00000011834; -.
DR   BindingDB; Q5U3Y7; -.
DR   ChEMBL; CHEMBL4105864; -.
DR   DrugCentral; Q5U3Y7; -.
DR   GuidetoPHARMACOLOGY; 2553; -.
DR   PhosphoSitePlus; Q5U3Y7; -.
DR   PaxDb; 10116-ENSRNOP00000011834; -.
DR   Ensembl; ENSRNOT00000011808.5; ENSRNOP00000011834.3; ENSRNOG00000008704.7.
DR   Ensembl; ENSRNOT00055044833; ENSRNOP00055036733; ENSRNOG00055025980.
DR   Ensembl; ENSRNOT00060034347; ENSRNOP00060028180; ENSRNOG00060019874.
DR   Ensembl; ENSRNOT00065040732; ENSRNOP00065033221; ENSRNOG00065023773.
DR   GeneID; 303330; -.
DR   KEGG; rno:303330; -.
DR   AGR; RGD:1307423; -.
DR   CTD; 27346; -.
DR   RGD; 1307423; Tmem97.
DR   eggNOG; ENOG502RZRX; Eukaryota.
DR   GeneTree; ENSGT00940000158363; -.
DR   HOGENOM; CLU_086812_1_0_1; -.
DR   InParanoid; Q5U3Y7; -.
DR   OrthoDB; 5390811at2759; -.
DR   PhylomeDB; Q5U3Y7; -.
DR   TreeFam; TF300241; -.
DR   PRO; PR:Q5U3Y7; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000022657; Expressed in pancreas and 20 other cell types or tissues.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0030867; C:rough endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015485; F:cholesterol binding; ISS:UniProtKB.
DR   GO; GO:0008142; F:oxysterol binding; ISS:UniProtKB.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISS:UniProtKB.
DR   GO; GO:0140077; P:positive regulation of lipoprotein transport; ISS:UniProtKB.
DR   GO; GO:0090303; P:positive regulation of wound healing; ISS:UniProtKB.
DR   GO; GO:0032383; P:regulation of intracellular cholesterol transport; ISS:UniProtKB.
DR   GO; GO:0032377; P:regulation of intracellular lipid transport; ISS:UniProtKB.
DR   InterPro; IPR033118; EXPERA.
DR   InterPro; IPR051987; Sigma-2_receptor-like.
DR   InterPro; IPR016964; Sigma2_recept.
DR   PANTHER; PTHR31204; SIGMA INTRACELLULAR RECEPTOR 2; 1.
DR   PANTHER; PTHR31204:SF1; SIGMA INTRACELLULAR RECEPTOR 2; 1.
DR   Pfam; PF05241; EBP; 1.
DR   PIRSF; PIRSF031032; TMP_97_prd; 1.
DR   PROSITE; PS51751; EXPERA; 1.
PE   2: Evidence at transcript level;
KW   Endoplasmic reticulum; Membrane; Nucleus; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..176
FT                   /note="Sigma intracellular receptor 2"
FT                   /id="PRO_0000254570"
FT   TOPO_DOM        1..9
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q12155"
FT   TRANSMEM        10..30
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        31..68
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:Q12155"
FT   TRANSMEM        69..89
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        90..99
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q12155"
FT   TRANSMEM        100..120
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        121..140
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:Q12155"
FT   TRANSMEM        141..161
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        162..176
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q12155"
FT   DOMAIN          10..158
FT                   /note="EXPERA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01087"
FT   MOTIF           172..176
FT                   /note="ER retention motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q5BJF2"
FT   BINDING         75
FT                   /ligand="cholesterol"
FT                   /ligand_id="ChEBI:CHEBI:16113"
FT                   /evidence="ECO:0000250|UniProtKB:Q3MHW7"
FT   BINDING         77
FT                   /ligand="cholesterol"
FT                   /ligand_id="ChEBI:CHEBI:16113"
FT                   /evidence="ECO:0000250|UniProtKB:Q3MHW7"
FT   SITE            56
FT                   /note="Likely important for receptor folding"
FT                   /evidence="ECO:0000250|UniProtKB:Q5BJF2"
FT   SITE            150
FT                   /note="Important for 20(S)-OHC binding and
FT                   stereoselectivity"
FT                   /evidence="ECO:0000250|UniProtKB:Q5BJF2"
SQ   SEQUENCE   176 AA;  20946 MW;  949F3A588243B486 CRC64;
     MGAVTARRCV EWLLGLYFVS HIPITMFIDL QALLPPELYP QEFSNLLRWY SKEFKDPLMQ
     EPPVWFKSFL FCELVFQLPF FPIAAYAFFK GSCRWIRIPA IIYAVHTITT LIPILYTILF
     EDFSKAIAFK GQRPENFRER LTLVGVYAPY LIIPLILLLF MLRNPYYKFE EKRKKK
//
